Breaking News
Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started

Is Second Sight Medical Products a Winner in the Healthcare Sector?

Published Jun 08, 2021 11:03AM ET Updated Jun 08, 2021 12:30PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Is Second Sight Medical Products a Winner in the Healthcare Sector?
 
VANI
+0.99%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Second Sight Medical Products (NASDAQ:EYES) has found a market niche for itself in the healthcare space developing implantable visual prosthetics to treat sight-impaired people. With the U.S. FDA approval for its Argus 2s Retinal Prosthesis System in hand, can the stock keep soaring in the coming months? Let’s find out.Second Sight Medical Products, Inc. (EYES) has been in operation for more than two decades. It develops, manufactures and markets implantable visual prosthetics that are designed to deliver artificial vision to sight-impaired individuals. EYES’ shares soared to hit their 52-week high of $20 on March 9, following the FDA’s approval of its Argus 2s Retinal Prosthesis System. The stock has rallied 20.9% over the past three months to close yesterday’s trading session at $7.

According to Business Wire, the Vision Care market is expected to grow at a 4.31% CAGR between 2019 and 2027.

However, EYES’ next generation Orion Visual Cortical Prosthesis System is still under development. Also, the company is alleged to have violated its MOU with Pixium Vision SA. So, with a narrow portfolio of products and solutions, EYES’ prospects look bleak.

Continue reading on StockNews

Is Second Sight Medical Products a Winner in the Healthcare Sector?
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email